New Zealand's leap into gene therapy.
Marshall
E
E
D000581:Amidohydrolases / Q000235:genetics*; D017825:Canavan Disease / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D004274:DNA, Recombinant; D026724:Ethical Review; D005260:Female; D030342:Genetic Diseases, Inborn; D015316:Genetic Therapy / Q000331:legislation & jurisprudence; D005822:Genetic Vectors; D033161:Government Regulation; D006801:Humans; D007223:Infant; D038622:Internationality; D009316:National Institutes of Health (U.S.); D009520:New Zealand; D033281:Nontherapeutic Human Experimentation; D014481:United States
D004274:DNA, Recombinant; D000581:Amidohydrolases; C019751:aspartoacylase